Pharmacokinetics of cytosine arabinoside in patients with acute myeloid leukaemia.-Reference-Cited by-同舟云学术

Pharmacokinetics of cytosine arabinoside in patients with acute myeloid leukaemia.

Published:1979-09 Issue:3 Volume:8 Page:219-227
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:British Journal of Clinical Pharmacology

Author:

Harris AL,Potter C,Bunch C,Boutagy J,Harvey DJ,Grahame-Smith DG

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.1979.tb01005.x/fullpdf

Reference32 articles.

1. Plasma half-life of cytosine arabinoside (NSC-t3878) in patients treated for acute myeloblastic leukaemia;BAGULEY;Cancer Chemother. Rep.,1971

2. Progress in the treatment of adults with acute leukaemia;BODEY;Arch. intern. Med.,1976

3. Determination of cytosine arabinoside in human plasma by gas chromatography with a nitrogen sensitive detector and by gas chromatography mass spectrometry;BOUTAGY;J. Chromatog.,1978

4. Analysis of cytosine arabinoside and related pyrimidine nucleosides by gas chromatography and gas chromatography-mass spectrometry;BOUTAGY;J. Chromatog.,1979

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral cytarabine ocfosfate pharmacokinetics and assessment of leukocyte biomarkers in normal dogs;Journal of Veterinary Internal Medicine;2023-09-05

2. A multivalent Ara-C-prodrug nanoconjugate achieves selective ablation of leukemic cells in an acute myeloid leukemia mouse model;Biomaterials;2022-01

3. Oligonucleotides carrying nucleoside antimetabolites as potential prodrugs;Current Medicinal Chemistry;2021-11-29

4. BST-236, a novel cytarabine prodrug for patients with acute leukemia unfit for standard induction: a phase 1/2a study;Blood Advances;2019-11-26

5. Pharmacodynamics of cytarabine induced leucopenia: a retrospective cohort study;British Journal of Clinical Pharmacology;2015-03-23